Bicalutamide and Capecitabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bicalutamide (bicalutamide) and Capecitabine (capecitabine). Common drug interactions include malignant neoplasm progression among females and disease progression among males.

The phase IV clinical study analyzes what interactions people have when they take Bicalutamide and Capecitabine. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Bicalutamide?

Bicalutamide has active ingredients of bicalutamide. It is often used in prostate cancer. eHealthMe is studying from 9,930 Bicalutamide users. Check the latest studies of Bicalutamide.

What is Capecitabine?

Capecitabine has active ingredients of capecitabine. eHealthMe is studying from 59,495 Capecitabine users. Check the latest studies of Capecitabine.

On Jul, 16, 2026

24 people who take Bicalutamide and Capecitabine together, and have interactions are studied.

Bicalutamide and Capecitabine drug interactions.

What are the common drug interactions of Bicalutamide and Capecitabine, by gender? *:

female:

Malignant neoplasm progression (cancer tumour came back)
Metastases to liver (cancer spreads to liver)
Metastases to lung (cancer spreads to lung)
Disease progression
Metastases to lymph nodes (cancer spreads to lymph node)
Metastases to skin (cancer spreads to skin)
Abdominal discomfort
Alopecia (absence of hair from areas of the body)
Asthenia (weakness)
Decreased appetite

male:

Disease progression
Fatigue (feeling of tiredness)
Drug intolerance (drug sensitivity)
Extramammary paget's disease (cancer of an epithelium that originates in glandular tissue)
Hypercholesterolaemia (high levels of cholesterol in the blood)
Metastases to central nervous system (cancer spreads to central nervous system)
Metastases to eye (cancer spreads to eye)
Rectal cancer (cancer of rectum)
Thrombocytopenia (decrease of platelets in blood)
Walking disability

What are the common drug interactions of Bicalutamide and Capecitabine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Malignant neoplasm progression (cancer tumour came back)
Metastases to liver (cancer spreads to liver)
Metastases to lung (cancer spreads to lung)

40-49:

Cardiotoxicity (damage to the heart muscle)
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)

50-59:

Disease progression
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Anaemia (lack of blood)
Asthenia (weakness)
Depressed mood
Mobility decreased (ability to move is reduced)
Drug intolerance (drug sensitivity)
Extramammary paget's disease (cancer of an epithelium that originates in glandular tissue)
Walking disability

60+:

Hypertension (high blood pressure)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Chills (felling of cold)
Decreased appetite
Eye irritation
Fall
Oral mucosal blistering (mouth ulcer)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Palpitations (feelings or sensations that your heart is pounding or racing)

What are the existing conditions these people have? *

Extramammary Paget's Disease (cancer of an epithelium that originates in glandular tissue): 6 people, 25.00%
Neoplasm Malignant (cancer tumour): 2 people, 8.33%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 8.33%
Breast Cancer Stage Iv: 2 people, 8.33%
Breast Cancer: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Bicalutamide and Capecitabine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously